Literature DB >> 17991493

Increased protein SUMOylation following focal cerebral ischemia.

Helena Cimarosti1, Camilla Lindberg, Signe F Bomholt, Lars C B Rønn, Jeremy M Henley.   

Abstract

Stroke is a major cause of death and disability, which involves excessive glutamate receptor activation leading to excitotoxic cell death. We recently reported that SUMOylation can regulate kainate receptor (KAR) function. Here we investigated changes in protein SUMOylation and levels of KAR and AMPA receptor subunits in two different animal stroke models: a rat model of focal ischemia with reperfusion and a mouse model without reperfusion. In rats, transient middle cerebral artery occlusion (MCAO) resulted in a striatal and cortical infarct. A dramatic increase in SUMOylation by both SUMO-1 and SUMO-2/3 was observed at 6h and 24h in the striatal infarct area and by SUMO-2/3 at 24h in the hippocampus, which was not directly subjected to ischemia. In mice, permanent MCAO resulted in a selective cortical infarct. No changes in SUMOylation occurred at 6h but there was increased SUMO-1 conjugation in the cortical infarct and non-ischemic hippocampus at 24h after MCAO. Interestingly, SUMOylation by SUMO-2/3 occurred only outside the infarct area. In both rat and mouse levels of KARs were only decreased in the infarct regions whereas AMPARs were decreased in the infarct and in other brain areas. These results suggest that posttranslational modification by SUMO and down-regulation of AMPARs and KARs may play important roles in the pathophysiological response to ischemia.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17991493     DOI: 10.1016/j.neuropharm.2007.09.010

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  56 in total

Review 1.  SUMO rules: regulatory concepts and their implication in neurologic functions.

Authors:  Mathias Droescher; Viduth K Chaugule; Andrea Pichler
Journal:  Neuromolecular Med       Date:  2013-08-30       Impact factor: 3.843

Review 2.  The Roles of SUMO in Metabolic Regulation.

Authors:  Elena Kamynina; Patrick J Stover
Journal:  Adv Exp Med Biol       Date:  2017       Impact factor: 2.622

3.  Selective antegrade cerebral perfusion reduces brain injury following deep hypothermic circulatory arrest in the piglets' model by decreasing the levels of protein SUMO2/3-ylation.

Authors:  Bin Li; Yaobin Zhu; Aijun Liu; Wei Lu; Junwu Su; Jing Zhang; Zhiqiang Li; Xiangming Fan; Yinglong Liu
Journal:  Int J Clin Exp Med       Date:  2014-11-15

4.  Patterns of ubiquitylation and SUMOylation associated with exposure to anoxia in embryos of the annual killifish Austrofundulus limnaeus.

Authors:  Camie L Meller; Robert Meller; Roger P Simons; Jason E Podrabsky
Journal:  J Comp Physiol B       Date:  2013-12-14       Impact factor: 2.200

Review 5.  Significance of Mitochondrial Protein Post-translational Modifications in Pathophysiology of Brain Injury.

Authors:  Nina Klimova; Aaron Long; Tibor Kristian
Journal:  Transl Stroke Res       Date:  2017-09-21       Impact factor: 6.829

6.  Small ubiquitin-related modifier (SUMO)-1 promotes glycolysis in hypoxia.

Authors:  Terence A Agbor; Alex Cheong; Katrina M Comerford; Carsten C Scholz; Ulrike Bruning; Ambrose Clarke; Eoin P Cummins; Gerard Cagney; Cormac T Taylor
Journal:  J Biol Chem       Date:  2010-12-01       Impact factor: 5.157

Review 7.  Post-translational regulation of neuronal nitric oxide synthase: implications for sympathoexcitatory states.

Authors:  Neeru M Sharma; Kaushik P Patel
Journal:  Expert Opin Ther Targets       Date:  2016-12-02       Impact factor: 6.902

8.  SUMO1 promotes Aβ production via the modulation of autophagy.

Authors:  Sun-Jung Cho; Sang-Moon Yun; Chulman Jo; Dae-Hoon Lee; Ki Ju Choi; Jae Chun Song; Sang Ick Park; You-Jin Kim; Young Ho Koh
Journal:  Autophagy       Date:  2015       Impact factor: 16.016

Review 9.  SUMO and ischemic tolerance.

Authors:  Yang-ja Lee; John M Hallenbeck
Journal:  Neuromolecular Med       Date:  2013-06-18       Impact factor: 3.843

Review 10.  Sumoylation in neurodegenerative diseases.

Authors:  Petranka Krumova; Jochen H Weishaupt
Journal:  Cell Mol Life Sci       Date:  2012-09-25       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.